ci 988 has been researched along with spiroglumide in 1 studies
| Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (spiroglumide) | Trials (spiroglumide) | Recent Studies (post-2010) (spiroglumide) |
|---|---|---|---|---|---|
| 147 | 8 | 14 | 7 | 1 | 0 |
| Protein | Taxonomy | ci 988 (IC50) | spiroglumide (IC50) |
|---|---|---|---|
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 1.3115 | |
| Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 1.223 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 1.223 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Tullio, P; Delarge, J; Pirotte, B | 1 |
1 review(s) available for ci 988 and spiroglumide
| Article | Year |
|---|---|
Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Humans; Indoles; Keto Acids; Ligands; Meglumine; Peptoids; Proglumide; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spiro Compounds; Structure-Activity Relationship; Tetragastrin | 1999 |